Team:HKUST-Hong Kong/Module

From 2012.igem.org

(Difference between revisions)
 
Line 357: Line 357:
           </div>
           </div>
         </div>
         </div>
-
<div><p align="center"><font size="20">MODULE</font></p></div>
+
<div><p align="center"><font size="20">Module</font></p></div>
           <div id="paragraph1" class="bodyParagraphs">
           <div id="paragraph1" class="bodyParagraphs">

Latest revision as of 00:53, 27 September 2012

Team:HKUST-Hong Kong - 2012.igem.org

Module

Target Binding Module

Our decision to pursue colorectal carcinoma suppression arose from two key points obtained from preliminary research: 1) bone morphogenetic protein 2 (BMP-2) suppresses the growth of colon cancer cell growth in vivo, and 2) the phage display peptide RPMrel confers specific and preferential binding to non-differentiated colon cancer cells......Click to see more

Anti-tumor Molecule Secretion Module

As our team objective is to provide a specific and efficient drug for Colon cancer, the way of drug synthesis and releasing is a significant part of our whole project. Hence this module is focusing on the production and delivery of anti-tumor drug......click to see more

Regulation and Control Module

Our module aims at regulating our synthetic bacteria B. hercules. We first introduce a xylose inducible promoter, which can help us control the timing of BMP-2 expression. Our choice of xylose as an inducer stems from its induction efficiency, its little existence and low absorption rate in colon......click here to see more